AzTrials
AzTrials

Electronic Cigarette UseNCT06177158

Efficacy of Oral Hygiene Instructions on Proinflammatory Cytokines Among Cigarette Smokers and Individuals Vaping Electronic Cigarettes During Plaque Induced Gingivitis (Clinical Trial)

A study testing oral hygiene instructions in people with Electronic Cigarette Use and Plaque Induced Gingivitis, run by University of Baghdad.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To evaluate the level of proinflammatory cytokines in individual vaping electronic cigarette in gingivitis patients. Can vaping affects the proinflammatory cytokines level in diseased individuals? Group I: cigarette smoker with gingivitis. Group II: electronic cigarette smoker with gingivitis. Read more about this study

Who is it for?
Any age, men onlyHealthy volunteers can take part
What is being tested?
oral hygiene instructions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
39 participants
Where
No sites listed yet
Study dates
20 Dec 2023to 20 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Men only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • the included participant will be patients smoking cigarette at least 12 months no more than 8 cigarettes per day, patients use electronic vape in categories of low to medium dependance according to the Penn state electronic cigarette dependence index (one time consist of around 15 puffs or last around ten minutes). participants who never consumed tobacco in any form during their lifetime, having minimum of 20 teeth, additionally, all of involved patients having generalized gingivitis with intact periodontium in which they have more than 10% bleeding sites with no PPD >3 mm with no clinical attachment loss according to criteria proposed by (Chapple in,2018).

Who cannot join

  • dual smokers, smokeless tobacco, heavy smokers, patient using high nicotine formula (more than 25 mg/ml), periodontitis patient, patient with systemic diseases, females, participants who had used antibiotics, steroidal or non-steroid anti-inflammatory drugs within the past 6 months, patients who had undergone periodontal therapy within the last 6 months and patients unwilling to participate in study.

Trial locations and contacts

No sites are listed yet.

About this study

To evaluate the level of proinflammatory cytokines in individual vaping electronic cigarette in gingivitis patients.

Can vaping affects the proinflammatory cytokines level in diseased individuals?

Group I: cigarette smoker with gingivitis. Group II: electronic cigarette smoker with gingivitis. Group III: non-smoker with gingivitis.

participants will be asked to perform oral hygiene instructions.

measurement of inflammatory biomarkers MMP8 and MMP9 base line and after intervention will be done.

Read the detailed description

Periodontal diseases are defined as an inflammatory process associated with bacterial activity and mediated by the host's immunologic response (Armitage, 1999; Tonetti et al., 2018). Gingivitis, a reversible form of periodontal disease, is initially characterized by gingival inflammation cause by bacterial colonization forming the biofilm (Armitage, 1999; Tonetti et al., 2018). Cigarette smoking is a classical risk factor for both periodontal and peri-implant tissue damage (Sgolastra et al., 2013). It has been shown that patients who smoke suffer from more severe forms of periodontitis (Javed et al., 2013).

Disease progression is directly related to the frequency of smoking, where heavy smokers show more severe forms of the disease compared to light smokers (Tonetti et al., 2018). Different studies categorize the frequency of smoking differently but according to one review, smoking less than 9 cigarettes per day is considered light, and more than 31 is considered heavy smoking (Johnson \& Guthmiller, 2000). Smoking also impacts the response to periodontal treatment; smokers show only 50%-75% improvement in their clinical parameters after scaling and root planing compared to non-smokers (Tonetti et al., 2018).

Another study analyzed the effects of cigarette smoking on periodontal parameters and found significant increases in plaque index, pocket depth, and clinical attachment loss levels in cigarette smokers compared to non-smokers (Javed et al., 2017). It has been evidenced that tobacco smoking results in a proinflammatory effect by stimulating the secretion of specific cytokines and radical oxygen species (ROS) that play a role in the destruction of periodontal tissues (Katz et al., 2005) Electronic cigarettes (e-cigs) are battery-operated handheld devices, in which an e-liquid (contain ning nicotine and sometimes artificial flavors such as menthol, coffee, candy, butter and fruits) is heated by a heating element releasing a chemical-filled aerosol for inhalation (Sundar et al., 2016).

In the United States (U.S.), the use e-cigs is escalating predominantly in younger adults (Delnevo et al., 2015). Vaping without nicotine still proposes risks of exposure to the chemicals that are released in the heating process of the device, such as aluminum, copper, and lead (Gaur \& Agnihotri, 2019). E-cigarettes also pose a hazard for traumatic injuries. Blast injuries caused by battery explosion are also an associated risk, mainly in countries where there is no regulation on the manufacture and safety of e-cigarettes (Kite et al., 2016).

Focusing on a correlation between oral health and vaping, a recent study showed that e-cigarette exposure-mediated carbonyl stress leads to increased levels of prostaglandin-E2 and cyclooxygenase-2 in human gingival epithelium compared to control (Lerner et al., 2015) Several studies analyzed the impact of vaping on periodontal parameters and found increased levels of plaque index, pocket depth, clinical attachment loss, and marginal bone loss in vaping groups compared to non-smokers (Al-Aali et al., 2018) Despite all the evidence that smoking can negatively affect the periodontal tissues, there is still little evidence about the impact of vaping(Figueredo et al., 2020).

So, the research question of current study will be: can vaping affect the level of proinflammatory cytokines in diseased samples.

Aim To evaluate the level of proinflammatory cytokines in individual vaping electronic cigarette in gingivitis patients.

Rationale Vaping can affect the periodontal health in many ways, a better understanding about the impact of vaping on periodontal health could pave the way to develop a better treatment plan for those patients.

Research Hypothesis

Null hypothesis: vaping has no effect on the proinflammatory cytokines level in diseased individuals.

Alternative hypothesis vaping affects the proinflammatory cytokines level in diseased individuals.

Methodology

Settings:

The study will be conducted at College of Dentistry/University of Baghdad / Iraq the study will be started at December 2023 till June 2024.

Adherence Printed follow-up schedule cards with reminder calls or messages will be utilized to remind the participants twice daily for brushing and using the intervention. Furthermore, the patient instructed to bring the container of mouth wash and interdental aids at the end point therapy.

Saliva collection and analysis Saliva will be collected as previously described before clinical examination (Zhang, Y et al, 2021). Participants will be asked to refrain from eating, drinking, or engaging in oral hygiene procedures for at least two hours prior saliva collection. Then, participants will rinse their mouths with tap water for 30 s approximately 10 min prior to saliva collection and will be asked to expectorate into sterile tubes while sitting in an upright position until collecting 3 ml of unstimulated saliva. The quantification of the biomarker in saliva will be assayed using enzyme-linked immunoassay (ELISA).

Being tested
oral hygiene instructions
Keywords
smoking, Electronic Cigarette Use, Gingivitis
Medical subject headings
Vaping, Smoking, Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • oral hygiene instructionsBehavioural

    Standardized motivation and oral hygiene instructions regarding the tooth brushing will be demonstrated to all three groups using modified bass technique and a standardized brush, medium bristled brush with toothpaste, the patients will be instructed to brush their teeth for 2 minutes with a pea- size amount of dentifrice twice daily. For interdental cleaning aids each patient will be instructed to use the suitable methods regarding the space between teeth.

    clinically for each patient to ensure that the patients understood the instruction sessions. Before receiving oral hygiene instructions and motivation, the salivary sample will be collected and clinical periodontal parameters will be measured at a base line visit then, after 3 weeks, saliva will be collected and the same clinical measurements will be taken.

Study groups in NCT06177158
Study groupRoleWhat they receive
cigarette smoker with gingivitis.Active comparatororal hygiene instructions
Receives: Behavioral: oral hygiene instructions
electronic cigarette smoker with gingivitis.Active comparatororal hygiene instructions
Receives: Behavioral: oral hygiene instructions
non-smoker with gingivitis.Active comparatororal hygiene instructions
Receives: Behavioral: oral hygiene instructions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the reduction in periodontal parameters

    (PI,BOP and GI) between the baseline and the endpoints of the study.

    Measured: 3 weeks

Secondary outcomes (1)
  1. the changes between the baseline and 3 weeks for salivary matrix metalloproteinase 8 and 9 concentration.

    Measured: three weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2023
  2. Study start20 Dec 2023 (estimated)
  3. Primary completion20 Mar 2024 (estimated)
  4. Study completion20 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
39 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06177158
Sponsor's protocol ID
vaping effect on biomarkers
Status last verified
Dec 2023
First submitted
11 Dec 2023
Last updated
20 Dec 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing oral hygiene instructions in people with Electronic Cigarette Use and Plaque Induced Gingivitis, run by University of Baghdad.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Abdulrahman Khazaal, B.D.S (+9647830155200, abd.alaa2205@codental.uobaghdad.edu.iq), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the reduction in periodontal parameters (time frame: 3 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in